This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

Leila Akkari, Ph.D. group

Akkari, Leila

Leila Akkari, Ph.D.

Junior Group Leader

Personal details


I trained in cellular and molecular biology during my BA at the University of Montpellier in France, and graduated in 2004 before performing my Master in oncology and immunology between Montpellier and Manchester (England).

I then came back to Montpellier to perform my PhD in health sciences in the laboratory of Dr Ula Hibner, at the IGMM CNRS, during which I studied the effects of HCV viral proteins on cancer initiation through alteration of hepatocyte polarity and cell shape. This was my first encounter on how tumor-extrinsic factors can favor pre-neoplastic transformation.

Once my PhD finished, I wanted to develop my focus in the tumor microenvironment field, in rare tumors, and I joined Prof. Johanna Joyce's laboratory at Memorial Sloan Kettering Cancer Center in NYC. During this time, I began to work with mouse models of brain and pancreatic cancer, primarily focusing on tumor associated macrophages and their pro-tumorigenic roles in multiple tumor microenvironment. In 2017, I became a Junior Group Leader at the NKI.

Share this page